ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
SapioStrategic
|
236 |
98K |
1 |
09/05/24 |
09/05/24 |
ASX - By Stock
|
236
|
98K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
SapioStrategic
|
236 |
98K |
2 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
98K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
SapioStrategic
|
236 |
98K |
1 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
98K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
SapioStrategic
|
236 |
98K |
6 |
02/05/24 |
02/05/24 |
ASX - By Stock
|
236
|
98K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: CEO Presentation to 2023 Annual General Meeting
|
|
SapioStrategic
|
114 |
38K |
0 |
29/11/23 |
29/11/23 |
ASX - By Stock
|
114
|
38K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
SapioStrategic
|
11K |
3.4M |
2 |
28/11/23 |
28/11/23 |
ASX - By Stock
|
11K
|
3.4M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
SapioStrategic
|
1.0K |
408K |
13 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
408K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Submits New Information to FDA IND File for SR-aGVHD
|
|
SapioStrategic
|
576 |
208K |
6 |
05/10/22 |
05/10/22 |
ASX - By Stock
|
576
|
208K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2022 Full Year Financial Results Webcast
|
|
SapioStrategic
|
22 |
13K |
7 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
22
|
13K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2022 Full Year Financial Results Webcast
|
|
SapioStrategic
|
22 |
13K |
1 |
30/08/22 |
30/08/22 |
ASX - By Stock
|
22
|
13K
|
1
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
SapioStrategic
|
10K |
3.0M |
13 |
23/12/21 |
23/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
13
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Trading Halt
|
|
SapioStrategic
|
51 |
26K |
17 |
13/08/21 |
13/08/21 |
ASX - By Stock
|
51
|
26K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
SapioStrategic
|
157 |
47K |
3 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
157
|
47K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
SapioStrategic
|
157 |
47K |
2 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
157
|
47K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Management Update
|
|
SapioStrategic
|
157 |
47K |
7 |
10/08/21 |
10/08/21 |
ASX - By Stock
|
157
|
47K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Alzheimer drug approved
|
|
SapioStrategic
|
243 |
74K |
7 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
243
|
74K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Alzheimer drug approved
|
|
SapioStrategic
|
243 |
74K |
62 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
243
|
74K
|
62
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
SapioStrategic
|
300 |
87K |
1 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
87K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Q3 Financial Results Webcast
|
|
SapioStrategic
|
300 |
87K |
1 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
300
|
87K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Operational Highlights and Upcoming Milestones
|
|
SapioStrategic
|
177 |
57K |
9 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
177
|
57K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SapioStrategic
|
18K |
7.0M |
6 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
18K
|
7.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
SapioStrategic
|
18K |
7.0M |
1 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
18K
|
7.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Why Meso is pumping today?
|
|
SapioStrategic
|
109 |
43K |
5 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
109
|
43K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
SapioStrategic
|
555 |
270K |
1 |
02/10/20 |
02/10/20 |
ASX - By Stock
|
555
|
270K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
10 Sept 12pm NSW Stem Cell Network - Stem Cells vs COVID19
|
|
SapioStrategic
|
220 |
85K |
29 |
10/09/20 |
10/09/20 |
ASX - By Stock
|
220
|
85K
|
29
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading - Aug 2020 on
|
|
SapioStrategic
|
2.3K |
919K |
0 |
16/08/20 |
16/08/20 |
ASX - By Stock
|
2.3K
|
919K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
SapioStrategic
|
2.0K |
699K |
9 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
699K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
SapioStrategic
|
2.0K |
699K |
12 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
2.0K
|
699K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
FDA ODAC Meeting Material discussion analysis
|
|
SapioStrategic
|
491 |
194K |
17 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
491
|
194K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L
|
|
SapioStrategic
|
854 |
434K |
18 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
854
|
434K
|
18
|
|
ASX - By Stock
|
ASM |
Re:
Ann: SUCCESSFUL PRODUCTION OF Ti METAL FROM PILOT PLANT
|
|
SapioStrategic
|
19 |
8.8K |
1 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
19
|
8.8K
|
1
|
|
ASX - By Stock
|
ASM |
Re:
Ann: SUCCESSFUL PRODUCTION OF Ti METAL FROM PILOT PLANT
|
|
SapioStrategic
|
19 |
8.8K |
5 |
10/08/20 |
10/08/20 |
ASX - By Stock
|
19
|
8.8K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
SapioStrategic
|
425 |
193K |
2 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
425
|
193K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: EAP for Remestemcel-L in Children with MIS-C due to COVID-19
|
|
SapioStrategic
|
425 |
193K |
20 |
06/07/20 |
06/07/20 |
ASX - By Stock
|
425
|
193K
|
20
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
SapioStrategic
|
23K |
13M |
8 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
MSB Investment Case
|
|
SapioStrategic
|
17 |
11K |
1 |
23/06/20 |
23/06/20 |
ASX - By Stock
|
17
|
11K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Third Quarter Results Presentation
|
|
SapioStrategic
|
182 |
68K |
2 |
31/05/20 |
31/05/20 |
ASX - By Stock
|
182
|
68K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 3 Articles on RYONCIL GvHD Trial Results Published in BBMT
|
|
SapioStrategic
|
127 |
71K |
15 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
127
|
71K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
SapioStrategic
|
933 |
440K |
7 |
12/05/20 |
12/05/20 |
ASX - By Stock
|
933
|
440K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: 83% Survival in COVID-19 ARDS Patients with Remestemcel-L
|
|
SapioStrategic
|
847 |
340K |
15 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
847
|
340K
|
15
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Operations Update
|
|
SapioStrategic
|
34 |
15K |
0 |
30/03/20 |
30/03/20 |
ASX - By Stock
|
34
|
15K
|
0
|
|
ASX - By Stock
|
AKE |
Re:
Ann: Pause in Trading
|
|
SapioStrategic
|
20 |
8.2K |
4 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
20
|
8.2K
|
4
|
|
ASX - By Stock
|
AKE |
Re:
Ann: Pause in Trading
|
|
SapioStrategic
|
20 |
8.2K |
1 |
20/03/20 |
20/03/20 |
ASX - By Stock
|
20
|
8.2K
|
1
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Trading Halt
|
|
SapioStrategic
|
71 |
30K |
1 |
19/03/20 |
19/03/20 |
ASX - By Stock
|
71
|
30K
|
1
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Trading Halt
|
|
SapioStrategic
|
62 |
57K |
2 |
12/02/20 |
12/02/20 |
ASX - By Stock
|
62
|
57K
|
2
|
|
ASX - By Stock
|
PNR |
Re:
Ann: Appointment of Chairman
|
|
SapioStrategic
|
38 |
23K |
1 |
07/02/20 |
07/02/20 |
ASX - By Stock
|
38
|
23K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Submission of rolling BLA to the FDA for acute GVHD completed
|
|
SapioStrategic
|
60 |
31K |
3 |
17/12/19 |
17/12/19 |
ASX - By Stock
|
60
|
31K
|
3
|
|
ASX - By Stock
|
ALK |
Re:
Ann: Trading Halt
|
|
SapioStrategic
|
123 |
82K |
2 |
26/11/19 |
26/11/19 |
ASX - By Stock
|
123
|
82K
|
2
|
|
ASX - By Stock
|
AKE |
AustralianSuper backing in AFR article
|
|
SapioStrategic
|
0 |
471 |
8 |
11/11/19 |
11/11/19 |
ASX - By Stock
|
0
|
471
|
8
|
|
ASX - By Stock
|
MSB |
Re:
An industry Super Fund taking interest in Mesoblast.
|
|
SapioStrategic
|
1 |
1.1K |
2 |
05/10/19 |
05/10/19 |
ASX - By Stock
|
1
|
1.1K
|
2
|
|